a16z Live · 8 April 2021
At the source: Andreessen Horowitz ↗ · audio
On this episode of the a16z Bio Clubhouse Show, a16z general partners Vineeta Agarwala and Vijay Pande talk to guest Ben Oakes, cofounder, President and CEO of Scribe Therapeutics. The conversation covers the the power of engineering gene editors, the transition from academia to a startup, and how to select the first indication to target with a novel bio platform.
As published with the episode at a16z Live ↗
No summary of this episode yet.